Cytori Gains Stem Cell Device Approval In Europe For Breast Cancer Reconstruction And
Cytori Therapeutics (NASDAQ: CYTX) received expanded European approval (CE Mark) for its Celution® System, a medical device that extracts and separates stem and regenerative cells from a patient's own fat tissue...